212 related articles for article (PubMed ID: 29501865)
1. Nitric oxide donors for prostate and bladder cancers: Current state and challenges.
Seabra AB; Durán N
Eur J Pharmacol; 2018 May; 826():158-168. PubMed ID: 29501865
[TBL] [Abstract][Full Text] [Related]
2. Small molecules for great solutions: Can nitric oxide-releasing nanomaterials overcome drug resistance in chemotherapy?
Pieretti JC; Pelegrino MT; Nascimento MHM; Tortella GR; Rubilar O; Seabra AB
Biochem Pharmacol; 2020 Jun; 176():113740. PubMed ID: 31786262
[TBL] [Abstract][Full Text] [Related]
3. Sensitizing activities of nitric oxide donors for cancer resistance to anticancer therapeutic drugs.
Bonavida B
Biochem Pharmacol; 2020 Jun; 176():113913. PubMed ID: 32173364
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide donors: novel cancer therapeutics (review).
Huerta S; Chilka S; Bonavida B
Int J Oncol; 2008 Nov; 33(5):909-27. PubMed ID: 18949354
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of nitric oxide is a good therapeutic target for bladder tumors that express iNOS.
Belgorosky D; Langle Y; Prack Mc Cormick B; Colombo L; Sandes E; Eiján AM
Nitric Oxide; 2014 Jan; 36():11-8. PubMed ID: 24211345
[TBL] [Abstract][Full Text] [Related]
6. The regulation of nitric oxide in tumor progression and therapy.
Hu Y; Xiang J; Su L; Tang X
J Int Med Res; 2020 Feb; 48(2):300060520905985. PubMed ID: 32090657
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide signaling in human ovarian cancer: A potential therapeutic target.
El-Sehemy A; Postovit LM; Fu Y
Nitric Oxide; 2016 Apr; 54():30-7. PubMed ID: 26891890
[TBL] [Abstract][Full Text] [Related]
8. Regulation of TGF-beta1 gene transcription in human prostate cancer cells by nitric oxide.
Wang D; Lu S; Dong Z
Prostate; 2007 Dec; 67(16):1825-33. PubMed ID: 17941092
[TBL] [Abstract][Full Text] [Related]
9. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.
Yasuda H
Nitric Oxide; 2008 Sep; 19(2):205-16. PubMed ID: 18503779
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy.
Hirst D; Robson T
Curr Pharm Des; 2010; 16(4):411-20. PubMed ID: 20236069
[TBL] [Abstract][Full Text] [Related]
11. Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects.
Huang Z; Fu J; Zhang Y
J Med Chem; 2017 Sep; 60(18):7617-7635. PubMed ID: 28505442
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide releasing nanomaterials for cancer treatment: current status and perspectives.
Seabra AB; de Lima R; Calderón M
Curr Top Med Chem; 2015; 15(4):298-308. PubMed ID: 25579351
[TBL] [Abstract][Full Text] [Related]
13. Role of nitric oxide in the response to photooxidative stress in prostate cancer cells.
D'Este F; Della Pietra E; Badillo Pazmay GV; Xodo LE; Rapozzi V
Biochem Pharmacol; 2020 Dec; 182():114205. PubMed ID: 32828802
[TBL] [Abstract][Full Text] [Related]
14. Localization and expression of inducible nitric oxide synthase in patients after BCG treatment for bladder cancer.
Koskela LR; Poljakovic M; Ehrén I; Wiklund NP; de Verdier PJ
Nitric Oxide; 2012 Oct; 27(3):185-91. PubMed ID: 22819699
[TBL] [Abstract][Full Text] [Related]
15. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.
Puglisi MA; Cenciarelli C; Tesori V; Cappellari M; Martini M; Di Francesco AM; Giorda E; Carsetti R; Ricci-Vitiani L; Gasbarrini A
J Pathol; 2015 Aug; 236(4):479-90. PubMed ID: 25875314
[TBL] [Abstract][Full Text] [Related]
16. Applications for nitric oxide in halting proliferation of tumor cells.
Reynolds MM; Witzeling SD; Damodaran VB; Medeiros TN; Knodle RD; Edwards MA; Lookian PP; Brown MA
Biochem Biophys Res Commun; 2013 Feb; 431(4):647-51. PubMed ID: 23337501
[TBL] [Abstract][Full Text] [Related]
17. iNOS-selective inhibitors for cancer prevention: promise and progress.
Janakiram NB; Rao CV
Future Med Chem; 2012 Nov; 4(17):2193-204. PubMed ID: 23190107
[TBL] [Abstract][Full Text] [Related]
18. Controlled Delivery of Nitric Oxide for Cancer Therapy.
Alimoradi H; Greish K; Gamble AB; Giles GI
Pharm Nanotechnol; 2019; 7(4):279-303. PubMed ID: 31595847
[TBL] [Abstract][Full Text] [Related]
19. Maximizing outcomes in genitourinary cancers across the treatment continuum.
Fitzpatrick JM; Bellmunt J; Dreicer R; Fleshner NE; Logothetis CJ; Moul JW; Tombal B; Zlotta A
BJU Int; 2011 Apr; 107 Suppl 2():1-12. PubMed ID: 21382149
[TBL] [Abstract][Full Text] [Related]
20. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling.
Frederiksen LJ; Sullivan R; Maxwell LR; Macdonald-Goodfellow SK; Adams MA; Bennett BM; Siemens DR; Graham CH
Clin Cancer Res; 2007 Apr; 13(7):2199-206. PubMed ID: 17404104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]